InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Browse the complete record of transactions filed by Davis Aaron I., Director. Insider active across 3 companies, notably Odonate Therapeutics, Inc.. Cumulatively, 7 disclosures have been published. Split: 1 buy · 4 sells. Total volume traded: €5.7m. History available since 17 November 2021. The latest transaction was disclosed on 9 May 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations7 total
25,000 shares@ US$22.908910.7% of flowCommon StockSEC:0000899243-22-017712:0
150,000 shares@ US$27.402177.2% of flowCommon StockSEC:0000899243-22-016203:0
21,300 shares@ US$31.87512.2% of flowCommon StockSEC:0000899243-22-012152:0
Ideal exit: 17 Dec 2022 (T+270)
2,546 shares0Common StockSEC:0001214659-22-000842
2,546 shares0Common StockSEC:0001214659-22-000842:0
170,000 shares@ US$2.2334100.0% of flowCommon StockSEC:0000899243-21-045438
170,000 shares@ US$2.233450.0% of flowCommon StockSEC:0000899243-21-045438:0
7 of 7 declarations
About Davis Aaron I.
Aaron I. Davis is a Board Member at Odonate Therapeutics, Inc., Mirati Therapeutics, Inc., and iTeos Therapeutics, Inc. As a board member, he brings his expertise in biopharmaceuticals and strategy. His role is to oversee operations and contribute to strategic decision-making that influences the direction of the companies. He is committed to ensuring compliance and transparency within the organizations.
